These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 454535)

  • 21. Surface properties of glass containers for parenteral solutions.
    Adams PB
    Bull Parenter Drug Assoc; 1977; 31(5):213-26. PubMed ID: 922239
    [No Abstract]   [Full Text] [Related]  

  • 22. Stability of bleomycin sulfate reconstituted in 5% dextrose injection or 0.9% sodium chloride injection stored in glass vials or polyvinyl chloride containers.
    Koberda M; Zieske PA; Raghavan NV; Payton RJ
    Am J Hosp Pharm; 1990 Nov; 47(11):2528-9. PubMed ID: 1703725
    [No Abstract]   [Full Text] [Related]  

  • 23. [PVC in the containers of pharmaceutical and food products: technology, control and use].
    Galli A; Zanotti Gerosa A
    Boll Chim Farm; 1977 May; 116(5):285-99. PubMed ID: 889632
    [No Abstract]   [Full Text] [Related]  

  • 24. [The multiuse device for opening glass containers].
    Grande Baos C
    Rev Enferm; 1991 Sep; 14(157):65-6. PubMed ID: 1962125
    [No Abstract]   [Full Text] [Related]  

  • 25. Stability and compatibility of antitumor agents in glass and plastic containers.
    Benvenuto JA; Anderson RW; Kerkof K; Smith RG; Loo TL
    Am J Hosp Pharm; 1981 Dec; 38(12):1914-8. PubMed ID: 7325172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. General guidelines for the processing of glass containers for parenteral products.
    Anschel J
    Bull Parenter Drug Assoc; 1977; 31(1):47-52. PubMed ID: 831899
    [No Abstract]   [Full Text] [Related]  

  • 27. Sterilization of glass containers by laser initiated plasmas.
    Tensmeyer LG; Wright PE; Fegenbush DO; Snapp SW
    J Parenter Sci Technol; 1981; 35(3):93-7. PubMed ID: 7241290
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug safety: the viewpoint of the pharmaceutical manufacturing industry.
    Wigle WW
    Can Med Assoc J; 1968 Feb; 98(6):314-7. PubMed ID: 5636099
    [No Abstract]   [Full Text] [Related]  

  • 29. Nursing attitudes toward oral liquid unit dose packaging.
    Ryan MR; Rosenbluth SA; Martinez D; Schneider FM; Brown TR
    Am J Hosp Pharm; 1976 Jan; 33(1):58-60. PubMed ID: 1266867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Today's neutral glass. Glass on the Italian marker].
    Moretti C
    Boll Chim Farm; 1976 Feb; 115(2):80-8. PubMed ID: 949364
    [No Abstract]   [Full Text] [Related]  

  • 31. [Light transmittance and light-protective action of containers for phenylalkylamine solutions. 84: Contributions to problems concerning the use of plastic containers for liquid pharmaceutical preparations; 18: Stability of drugs and preparations].
    Grünert R; Wollmann H
    Pharmazie; 1983 Jan; 38(1):30-3. PubMed ID: 6844379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sterilization of ampoules (glass containers of 1-20 ml) followed by blue bath control.
    Schuck LJ
    Dev Biol Stand; 1974; 23():6-8. PubMed ID: 4459200
    [No Abstract]   [Full Text] [Related]  

  • 33. [Drugs in different containers].
    Hortobágyi G
    Orv Hetil; 1971 Aug; 112(34):2062. PubMed ID: 5131203
    [No Abstract]   [Full Text] [Related]  

  • 34. ESCA depth profiling studies of borosilicate glass containers.
    Borchert SJ; Maxwell RJ
    J Parenter Sci Technol; 1990; 44(3):153-82. PubMed ID: 2370625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selection of plastic containers for pharmaceuticals.
    Homrowski S
    Polim Med; 1977; 7(2):91-7. PubMed ID: 600885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between the DIN 52329 and U.S.P. 18. Methods for determining the chemical resistance of pharmaceutical glass containers to water attack.
    Mecarelli E; Branchi G; Bersellini L
    Farmaco Prat; 1969 Sep; 24(9):576-90. PubMed ID: 5350902
    [No Abstract]   [Full Text] [Related]  

  • 37. [Sorption of benzalkonium chloride and chlorohexidine acetate by plastic and glass containers of drugs].
    Kovács P; Takácsi Nagy G
    Acta Pharm Hung; 1981; 51(5):228-35. PubMed ID: 7324972
    [No Abstract]   [Full Text] [Related]  

  • 38. Manufacturing error in a propofol vial: glass within glass.
    Umesh G; Kaur N
    J Clin Anesth; 2012 Dec; 24(8):677. PubMed ID: 23228875
    [No Abstract]   [Full Text] [Related]  

  • 39. Stability of fluoride solutions in glass and plastic containers.
    Hattab F
    Acta Pharm Suec; 1981; 18(4):249-53. PubMed ID: 7315370
    [No Abstract]   [Full Text] [Related]  

  • 40. [NOTE ON THE "METHOD OF PHYSICAL AND CHEMICAL INSPECTION OF GLASS CONTAINERS FOR PHARMACEUTICAL USE" PROPOSED BY THE CIBA-ERBA-FARMITALIA-LEPETIT COMPANIES].
    MORETTI C
    Boll Chim Farm; 1964 Jan; 103():69-77. PubMed ID: 14133267
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.